Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022

George Hill Maintained (TDOC) at Hold with Decreased Target to $31 on, Sep 27th, 2022

George Hill of Deutsche Bank, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $34 to $31 on, Sep 27th, 2022.

George has made no other calls on TDOC in the last 4 months.



There are 13 other peers that have a rating on TDOC. Out of the 13 peers that are also analyzing TDOC, 9 agree with George's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Scott Schoenhaus of "Keybanc" Initiated at Hold on, Friday, September 16th, 2022
  • Jailendra Singh of "Truist Securities" Initiated at Hold and Held Target at $35 on, Wednesday, September 7th, 2022
  • Ravi Misra of "Berenberg" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Tuesday, August 2nd, 2022
  • Charles Rhyee of "Cowen & Co." Downgraded from Buy to Hold and Decreased Target to $34 on, Tuesday, August 2nd, 2022
  • Cindy Motz of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $36 on, Thursday, July 28th, 2022
  • Ryan MacDonald of "Needham" Downgraded from Strong Buy to Hold on, Thursday, July 28th, 2022
  • Stephanie Davis Demko of "SVB Leerink" Maintained at Hold with Decreased Target to $34 on, Thursday, July 28th, 2022
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $40 on, Thursday, July 28th, 2022
  • David Grossman of "Stifel" Maintained at Hold with Decreased Target to $36 on, Wednesday, June 29th, 2022


These are the ratings of the 4 analyists that currently disagree with George


  • Sandy Draper of "Guggenheim" Downgraded from Hold to Strong Sell and Held Target at $25 on, Wednesday, August 17th, 2022
  • Robert Simmons of "DA Davidson" Initiated at Strong Buy and Held Target at $45 on, Friday, August 12th, 2022
  • Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $40 on, Thursday, July 28th, 2022
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $55 on, Thursday, July 28th, 2022